Fair enough.
You can take my advice ot leave it but I wouldn't be buying anymore TTT shares if I were you. Not until they can show the market that they are able to generate Profits. I do not know what your average is & it is none of my business.
The more I analysis TTT, the more I am convinced that there is something wrong in their Finance structure/Profit margin.....hence no Sales to date.
I am not questioning their technology or TFK......This is all well & truly proven by CSIRO but TTT have not even sold a single golf club or Bike in 2 years now let alone a machine. What does this tell you? Calloway & Trek have all gome mysteriously quiet.
I am far less confident in TTT now then I was this time last year & with the greatest of respects, I am usually on the money..
- Forums
- ASX - By Stock
- TTT
- Ann: October 2019 Company Update
Ann: October 2019 Company Update, page-96
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add TTT (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
-0.010(8.00%) |
Mkt cap ! $131.4M |
Open | High | Low | Value | Volume |
13.0¢ | 13.8¢ | 11.5¢ | $291.5K | 2.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 232326 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 175000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 232326 | 0.115 |
13 | 247358 | 0.110 |
12 | 256689 | 0.105 |
18 | 392903 | 0.100 |
1 | 100000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 175000 | 4 |
0.125 | 52001 | 3 |
0.130 | 135447 | 4 |
0.135 | 147293 | 4 |
0.140 | 430901 | 5 |
Last trade - 14.43pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TTT (ASX) Chart |